| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/02/2005 | EP1318820B1 Medicament containing sub-anesthetic concentrations of xenon for use in the treatment of cardiovascular diseases |
| 02/02/2005 | EP1303521B1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 02/02/2005 | EP1303506B1 6-heteroarylphenanthridines |
| 02/02/2005 | EP1259550B1 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 02/02/2005 | EP1235574B1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 02/02/2005 | EP1218009B1 Quetiapine granules |
| 02/02/2005 | EP1135166B9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/02/2005 | EP1100523A4 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 02/02/2005 | EP1001760B1 Composition for controlling mood disorders in healthy individuals |
| 02/02/2005 | EP0981610B1 Compositions for treatment of disorders involving programmed cell death |
| 02/02/2005 | EP0862633B1 Virus protein antigens of the jc virus |
| 02/02/2005 | EP0852585B1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/02/2005 | EP0847275B1 Regulation of intracellular glucocorticoid concentrations |
| 02/02/2005 | EP0781143B1 Method of blocking the sec receptor |
| 02/02/2005 | CN1575340A Compositions and methods for treating neurodegenerative diseases |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575291A Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 02/02/2005 | CN1575290A Pyrimidine derivatives and pharmaceutical compositions containing that compounds |
| 02/02/2005 | CN1575289A 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same |
| 02/02/2005 | CN1575286A Thiophene-amd thiazolesulfonamides as antineoplastic agents |
| 02/02/2005 | CN1575282A Lactam compound |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575185A Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 02/02/2005 | CN1575182A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/02/2005 | CN1575179A Combination product comprising melagatran and dexamethasone |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1575173A Macrolides containing pharmaceutical compositions |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1575170A (-)-1-(3, 4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 02/02/2005 | CN1575163A Granule formulation |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572791A New benzothiazine and benzothiadiazine compounds, its preparation process and pharmaceutical composition containing said compounds |
| 02/02/2005 | CN1572790A New benzothiazine and benzothiadiazine compounds, its preparation process and pharmaceutical composition containing said compounds |
| 02/02/2005 | CN1572789A Use of certain crystal modifications of 1-(2, 6-difluorobenzyl)-1h-1, 2, 3-triazole-4-carboxamide in treating epilepsy |
| 02/02/2005 | CN1572326A Therapeutic compositions including bio-availability enhancers |
| 02/02/2005 | CN1572318A Composition containing dipeptide of histidine and alanine for reducing uric acid |
| 02/02/2005 | CN1187367C 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/02/2005 | CN1187354C Adenosine receptor antagonists and methods of making and using the same |
| 02/02/2005 | CN1187338C 5-phenyl-pyrimidine derivatives |
| 02/02/2005 | CN1187336C New imidazole derivatives |
| 02/02/2005 | CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/02/2005 | CN1187106C Dual adhesive transdermal drug delivery system |
| 02/02/2005 | CN1187077C Chinese herbal medicine for treating epilepsia |
| 02/02/2005 | CN1187076C Medicine for treating senile dementia and its preparation method |
| 02/02/2005 | CN1187075C Preparation method of fresh gastrodia whole powder |
| 02/02/2005 | CN1187061C Application of alcohol extract of sowthistle plant in preparing tobacco toxin resisting medicine |
| 02/02/2005 | CN1187058C Stem cell medicine for repairing damage of central nerve and its preparing process |
| 02/02/2005 | CN1187056C Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/02/2005 | CN1187053C Uses of sugar cortexin receptor antagon for production of phrenopathic medicine |
| 02/02/2005 | CN1187049C Patches containing buprenorphine |
| 02/02/2005 | CN1187048C MGluR 5 antagonists for treatment of pain and anxiety |
| 02/02/2005 | CN1187039C High potency dihydroergotamine compositions |
| 02/01/2005 | US6849749 Method for the preparation of citalopram |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849735 Making N-4-carboxyphenyl-3-(6-oxohydropurin-9-yl) propanamide starting from aminopropionic acid, ethyl p-aminobenzoate, and using aminocyanoacetamide |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849663 Particularly septic shock |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849644 For example, 7-(Indole-1-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline; treatment of depression, anxiety, Alzheimers disease, age related cognitive decline, Attention Deficit Disorder |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849642 Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ring |
| 02/01/2005 | US6849640 Such as 8-(2,4-dichlorophenyl)-2,3,4,4a,5,9b-hexahydro-1H-pyrido(4,3-b)indole for use as HT3 receptor antagonist, for treatment of depression and obesity |
| 02/01/2005 | US6849638 Phosphodiesterase enzyme 7b (pde7b) inhibitors; treating osteoporosis, osteopenia and asthma |
| 02/01/2005 | US6849637 Matrix metalloproteases (MMPs) inhibitors such as benzyl 4-benzyl-5-oxo-4H-(1,2,4)triazolo(4,3-a)quinazol-7-ylcarboxylate for inflammatory conditions such as rheumatoid arthritis or osteoarthritis, or cancer |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849631 Semicarbazides and their uses |
| 02/01/2005 | US6849630 Cyclized amino acid derivatives |
| 02/01/2005 | US6849625 Use in manufacture of a medicament for use as an anti-invasive agent in containment and/or treatment of solid tumor disease |
| 02/01/2005 | US6849624 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders |
| 02/01/2005 | US6849623 For use as human and veterinary medicine |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 02/01/2005 | US6849602 Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
| 02/01/2005 | US6849601 A conotoxin proteins is adrenergic blocking agents, treating disorders of urinary or cardiovascular conditions, having alpha 1-adrenoceptor antagonist activity |
| 02/01/2005 | US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons |
| 02/01/2005 | US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 02/01/2005 | US6849263 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 02/01/2005 | CA2320448C 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino]purines |
| 01/27/2005 | WO2005014589A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments |
| 01/27/2005 | WO2005007838A1 Cell diffrentiation inhibitor, cell culture method using the same, liquid culture medium and cultured cell line |
| 01/27/2005 | WO2005007655A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds |
| 01/27/2005 | WO2005007644A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/27/2005 | WO2005007642A2 Novel azaheterocyclic amides useful for treating pain |
| 01/27/2005 | WO2005007630A2 Aryl fused azapolycyclic compounds |
| 01/27/2005 | WO2005007614A1 Monoamine oxidase inhibitors |
| 01/27/2005 | WO2005007240A1 Combination treatment of neurological disorders comprising phospholipids |
| 01/27/2005 | WO2005007176A1 Remedy for internal administration against cranial nerve diseases containing mesenchymal cells as the active ingredient |
| 01/27/2005 | WO2005007168A1 A stable clozapine suspension formulation |
| 01/27/2005 | WO2005007167A1 Solid pharmaceutical preparation |
| 01/27/2005 | WO2005007154A1 Preventive and/or therapeutic agent for pain |
| 01/27/2005 | WO2005007148A1 Ambroxol for treating epilepsy |
| 01/27/2005 | WO2005006877A1 Compositions and methods for decreasing age-related deterioration in metal activities in companion animals |
| 01/27/2005 | WO2004098579A3 Combination of a glycine/nmda antagonist and a tachykinin nk-1 receptor antagonist for use in the treatment of neurodegeneration |
| 01/27/2005 | WO2004010998A8 Sustained-release tablet comprising reboxetine |